Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer

被引：0
|
作者：
Takashi Mizowaki
Yoshiki Norihisa
Kenji Takayama
Itaru Ikeda
Haruo Inokuchi
Kiyonao Nakamura
Tomomi Kamba
Takahiro Inoue
Toshiyuki Kamoto
Osamu Ogawa
Masahiro Hiraoka
机构：
[1] Kyoto University,Department of Radiation Oncology and Image
[2] Kyoto University,applied Therapy, Graduate School of Medicine
来源：
International Journal of Clinical Oncology | 2016年 / 21卷
关键词：
Localized prostate cancer; Neoadjuvant hormonal therapy; Intensity-modulated radiation therapy; Prostate-specific antigen failure-free survival; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：783 / 790
页数：7
相关论文
共 50 条
  • [41] Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: a population-based study
    Gandaglia, G.
    Karakiewicz, P. I.
    Briganti, A.
    Trinh, Q. D.
    Schiffmann, J.
    Tian, Z.
    Kim, S. P.
    Nguyen, P. L.
    Graefen, M.
    Montorsi, F.
    Sun, M.
    Abdollah, F.
    ANNALS OF ONCOLOGY, 2014, 25 (05) : 979 - 986
  • [42] Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma
    Zumsteg, Zachary S.
    Riaz, Nadeem
    Jaffery, Sana
    Hu, Man
    Gelblum, Daphna
    Zhou, Ying
    Mychalczak, Borys
    Zelefsky, Michael J.
    Wolden, Suzanne
    Rao, Shyam
    Lee, Nancy Y.
    ORAL ONCOLOGY, 2015, 51 (07) : 716 - 723
  • [43] 4-year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer
    Schulman, CC
    Debruyne, FMJ
    Forster, G
    Selvaggi, FP
    Zlotta, AR
    Witjes, WPJ
    EUROPEAN UROLOGY, 2000, 38 (06) : 706 - 713
  • [44] Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: a preliminary report of disease control
    Saracino, Biancamaria
    Petrongari, Maria Grazia
    Marzi, Simona
    Bruzzaniti, Vicente
    Sara, Gomellini
    Arcangeli, Stefano
    Arcangeli, Giorgio
    Pinnaro, Paola
    Giordano, Carolina
    Ferraro, Anna Maria
    Strigari, Lidia
    CANCER MEDICINE, 2014, 3 (05): : 1313 - 1321
  • [45] Preliminary Results of a Nearly Completed Phase 1-2 Trial Using Trimodality Therapy in Patients With Post Prostatectomy High-Risk Pathologic (p) T2-3N0M0 Prostate Cancer
    Kumar, P.
    Veldhuizen, P.
    Thompson, M. A.
    Shen, X.
    Coster, J.
    Pinski, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E250 - E250
  • [46] Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes
    Kotecha, Rupesh
    Djemil, Toufik
    Tendulkar, Rahul D.
    Reddy, Chandana A.
    Thousand, Richard A.
    Vassil, Andrew
    Stovsky, Mark
    Berglund, Ryan K.
    Klein, Eric A.
    Stephans, Kevin L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (03): : 960 - 964
  • [47] Clinical Outcomes of Stereotactic Body Radiation Therapy for T2N0M0 Non-Small Cell Lung Cancer
    Zhu, Y.
    Jiang, C.
    Chen, W.
    Lin, Q.
    Sun, X.
    Shao, K.
    Wu, H.
    Xu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1010 - S1010
  • [48] Survival outcomes of neoadjuvant hormone therapy plus external-beam radiotherapy with relatively early initiation of salvage hormone therapy to patients with T3-4N0M0 prostate cancer
    Mizowaki, T.
    Norihisa, Y.
    Ogura, M.
    Kamba, T.
    Inoue, T.
    Shimizu, Y.
    Ogawa, O.
    Hiraoka, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [49] HISTOPATHOLOGIC HIGH-RISK FACTORS INFLUENCING THE PROGNOSIS OF PATIENTS WITH EARLY BREAST-CANCER (T1N0M0)
    BILIK, R
    MOR, C
    WOLLOCH, Y
    DINTSMAN, M
    AMERICAN JOURNAL OF SURGERY, 1986, 151 (04): : 460 - 464
  • [50] High-dose-rate iridiuim-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer
    Jo, Y
    Hiratsuka, J
    Fujii, T
    Takenaka, A
    Imajo, Y
    Fujisawa, M
    UROLOGY, 2004, 64 (03) : 556 - 560
12345